Clinical trials
Completed Angioedemas, Hereditary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
112 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 7 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 8 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 11 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 10 |
| 2022 | 9 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 112 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shire | 37 |
| BioCryst Pharmaceuticals | 13 |
| Takeda | 13 |
| CSL Behring | 9 |
| KalVista Pharmaceuticals, Ltd. | 9 |
| Pharming Technologies B.V. | 8 |
| Ionis Pharmaceuticals, Inc. | 3 |
| Astria Therapeutics, Inc. | 2 |
| CENTOGENE GmbH Rostock | 2 |
| Istituti Clinici Scientifici Maugeri SpA | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Angioedemas, Hereditary | 112 |
| Angioedema | 13 |
| Genetic Diseases, Inborn | 5 |
| Hereditary Angioedema Types I and II | 4 |
| Rare Diseases | 3 |
| Cardiovascular Diseases | 2 |
| Hereditary Angioedema Type III | 2 |
| Hypersensitivity | 2 |
| Hypersensitivity, Immediate | 2 |
| Immune System Diseases | 2 |
Trials
Showing 51 to 75 of 112. Each trial links to its page on Pharma Observatory.
12 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.